View in EDS HTML Full Text PDF Full Text

Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.

Saved in:
Bibliographic Details
Title: Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.
Authors: Pool IA; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Otten AT; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Mian P; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Pharmacometrics Expertise Center of the Northern Netherlands, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pharmaceutical, Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Bourgonje AR; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, 10029 NY, USA.
Source: Journal of personalized medicine [J Pers Med] 2026 Feb 14; Vol. 16 (2). Date of Electronic Publication: 2026 Feb 14.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41745409
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pool+IA%22">Pool IA</searchLink>; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Otten+AT%22">Otten AT</searchLink>; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kosterink+JGW%22">Kosterink JGW</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dijkstra+G%22">Dijkstra G</searchLink>; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mian+P%22">Mian P</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Pharmacometrics Expertise Center of the Northern Netherlands, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; Department of Pharmaceutical, Technology and Biopharmacy, Groningen Research Institute of Pharmacy, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bourgonje+AR%22">Bourgonje AR</searchLink>; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.; The Dr. Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, 10029 NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101602269%22">Journal of personalized medicine</searchLink> [J Pers Med] 2026 Feb 14; Vol. 16 (2). <i>Date of Electronic Publication: </i>2026 Feb 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101602269 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2075-4426 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220754426%22">20754426 </searchLink><i>NLM ISO Abbreviation: </i>J Pers Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41745409
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/jpm16020119
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pool IA
      – PersonEntity:
          Name:
            NameFull: Otten AT
      – PersonEntity:
          Name:
            NameFull: Kosterink JGW
      – PersonEntity:
          Name:
            NameFull: Dijkstra G
      – PersonEntity:
          Name:
            NameFull: Mian P
      – PersonEntity:
          Name:
            NameFull: Bourgonje AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 02
              Text: 2026 Feb 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2075-4426
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of personalized medicine
              Type: main
ResultId 1